• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,415.35 231.99
( 0.31%)
Global Indices
Nasdaq
50,600.73 294.06
(0.58%)
Dow Jones
7,493.73 27.01
(0.36%)
Hang Seng
63,328.42 1,644.28
(2.67%)
Nikkei 225
10,474.02 30.55
(0.29%)
Forex
USD-INR
96.29 -0.42
(-0.43%)
EUR-INR
111.82 -0.44
(-0.39%)
GBP-INR
129.28 -0.40
(-0.31%)
JPY-INR
0.61 0.00
(-0.48%)

EQUITY - MARKET SCREENER

Eiko Lifesciences Ltd
Industry :  Chemicals
BSE Code
ISIN Demat
Book Value()
540204
INE666Q01016
42.7795752
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
22.95
71.11
EPS(TTM)
Face Value()
Div & Yield %
2.16
10
0
 

Board of REC accords in-principle approval for merger with PFC
Feb 06,2026
The board of REC in its meeting held on 06 February 2026 took note of the announcement made by the Hon'ble Finance Minister in the Union Budget 2026- 27 regarding proposed restructuring of Power Finance Corporation (PFC) and REC to achieve scale and improve efficiency in public sector NBFCs.

In line with the above and based on the information presented as well as detailed deliberations in this regard, the Board of REC has accorded its in-principle approval to proceed with restructuring in the form of a merger of REC and PFC and to formulate a detailed merger proposal in accordance with applicable laws and regulations, ensuring that the merged entity continues to remain as a 'Government Company' under the Companies Act, 2013 and other applicable laws.